Exact Sciences Corp.(EXAS),a molecular diagnostics company focusing on the early detection of colorectal cancer, Tuesday said that it had decided to sell its common stock shares through an under written public offering. The company, however did not disclose the size or price of the offering.
Jefferies & Company, Inc. and Robert W. Baird & Co. Inc. are acting as joint book-running managers for the offering, said Exact Sciences.
On Tuesday, Exact Sciences Corp closed at $10.29 per share on the NASDAQ.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.